Cyltezo

Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Boehringer Ingelheim
Humira
biosimilars
interchangeable biosimilars
Cyltezo
AbbVie
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Boehringer Ingelheim
AbbVie
Humira
interchangeable biosimilars
biosimilars
Cyltezo
FDA
Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie